GNPX Genprex, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 14, 2026
$2,63
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,42minimo 52 sett.
$55,00massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$1M
Ricavi
$0
i tuoi badge
Intervallo 52 sett.
$0–$55
Rating Analisti
BUY
Prezzo Obiettivo
·
P/E
·
ROE
-347.0%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
GNPX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$2.63
Capitalizzazione di Mercato (MRQ)
$1M
Ricavi
$0
ROE
-347.0%
Intervallo 52 sett.
$0–$55
GNPX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 16 Luglio 2026 | 1-for-22 | Inverso |
| 21 Ottobre 2025 | 1-for-50 | Inverso |
| 02 Febbraio 2024 | 1-for-40 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02020-12-31 → 2024-12-31
Flusso di cassa libero·2019-12-31 → 2022-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | GNPX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.1media 5 anni ≈1660.4 | ≈1660.4 | 0.8 | Sottovalutato | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -0.0media 5 anni ≈-1975.4 | ≈-1975.4 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.0media 5 anni ≈1714.0 | ≈1714.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | GNPX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -227.2%media 5 anni ≈-192.9% | ≈-192.9% | · | · | |
| ROE | -347.0%media 5 anni ≈-510.2% | ≈-510.2% | · | · |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | GNPX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 6.8media 5 anni ≈3.7 | ≈3.7 | 6.1 | In linea | |
| Quick Ratio | 3.6media 5 anni ≈3.4 | ≈3.4 | 5.7 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | GNPX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-35.4%
Prossimo report
Nov 12, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 31 Marzo 2026 | Mag 13, 2026 | $-0.64 | — | — |
| 31 Marzo 2025 | $-286.00 | $-460.02 | 37.8% | |
| 31 Dicembre 2024 | $-1265.00 | $-437.58 | -189.1% | |
| 30 Settembre 2024 | $-1353.00 | $-2165.46 | 37.5% | |
| 30 Giugno 2024 | $-150.00 | $-117.30 | -27.9% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | |
| R&D Expense | $9M | $11M | $18M | $12M | $9M | $7M | $2M | $971.4K | $289.9K | $354.9K | |
| SG&A Expense | $6M | $11M | $13M | $12M | $12M | $11M | $9M | $11M | $3M | $4M | |
| Operating Expenses | $16M | $21M | $31M | $24M | $21M | $18M | $11M | $12M | $3M | $4M | |
| Operating Income | $-16M | $-21M | $-31M | $-24M | $-21M | $-18M | $-11M | $-12M | $-3M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | $38.0K | $1.9K | $0 | |
| Interest Income | · | $63.6K | $215.1K | $90.1K | $5.1K | $18.8K | $27.9K | $29.2K | $80 | $0 | |
| Other Non-op | · | · | · | · | · | · | · | $-8.8K | $-1.8K | $0 | |
| Income Tax | $0 | $2.6K | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-16M | $-21M | $-31M | $-24M | $-21M | $-18M | $-11M | $-12M | $-3M | $-4M | |
| EPS (Basic) | $-17.40 | $-266.89 | $-22.56 | $-19.80 | $-0.44 | · | · | · | · | · | |
| Shares (Basic) | 932,730 | 80,139 | 1,367,747 | 1,198,837 | 47,097,251 | · | · | · | · | · | |
| EBITDA | $-16M | $-21M | $-31M | $-24M | $-20M | $-18M | $-11M | · | $-3M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $2M | $7M | $21M | $39M | $27M | $2M | $9M | $161.3K | $2M | |
| Receivables | · | · | $0 | $34.9K | $0 | $127 | $655 | $9.3K | $8.8K | $8.2K | |
| Prepaid Expense | $525.9K | $475.8K | $794.1K | $484.2K | $511.3K | $384.6K | $171.7K | $236.9K | $23.5K | $28.4K | |
| Current Assets | $8M | $2M | $8M | $21M | $39M | $28M | $3M | $9M | $193.6K | $2M | |
| PP&E (Net) | $0 | $0 | $7.9K | $23.0K | $48.6K | $39.4K | $44.7K | $24.4K | $7.8K | $5.2K | |
| Intangibles | · | $0 | $773.5K | $702.1K | $642.4K | $601.6K | $491.2K | $379.5K | $298.6K | $241.0K | |
| Other Non-current Assets | $2M | $2M | $3M | $4M | $4M | $4M | $512.9K | $397.5K | $1M | $266.5K | |
| Total Assets | $10M | $4M | $11M | $25M | $43M | $31M | $4M | $9M | $1M | $2M | |
| Accounts Payable | $743.1K | $1M | $1M | $442.9K | $973.2K | $193.0K | $436.3K | $295.1K | $629.1K | $285.7K | |
| Current Liabilities | $2M | $3M | $3M | $3M | $2M | $450.7K | $510.7K | $387.8K | $831.0K | $285.7K | |
| Total Liabilities | $2M | $3M | · | · | $2M | · | · | · | · | · | |
| Common Stock | $150 | $217 | $1.5K | $1.2K | $47.9K | $43.1K | $19.3K | $15.2K | $11.7K | $11.4K | |
| Paid-in Capital | $179M | $156M | $141M | $125M | $120M | $89M | $43M | $39M | $18M | $16M | |
| Retained Earnings | $-171M | $-155M | $-134M | $-103M | $-79M | $-58M | $-40M | $-30M | $-17M | $-14M | |
| Stockholders' Equity | $8M | $2M | $7M | $22M | $41M | $31M | $3M | $9M | $428.6K | $2M | |
| Liabilities + Equity | $10M | $4M | $11M | $25M | $43M | $31M | $4M | $9M | $1M | $2M | |
| Shares Outstanding | 149,811 | 217,234 | 1,485,902 | 1,202,677 | 47,874,708 | 43,117,681 | 19,263,841 | 15,239,148 | 11,721,584 | 11,364,167 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | $3M | $5M | $5M | $5M | $4M | $4M | $5M | $1M | $3M | |
| Deferred Tax | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | · | $773.5K | $0 | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-15M | $-18M | $-25M | $-18M | $-14M | $-14M | $-7M | $-7M | $-2M | $-1M | |
| CapEx | · | · | · | $0 | $31.7K | $17.6K | $33.4K | $22.4K | $5.9K | $5.0K | |
| Investing Cash Flow | $0 | $774.6K | $-71.2K | $-59.7K | $-83.8K | $-2M | $-946.9K | $-103.3K | $-63.4K | $-89.5K | |
| Stock Issued | $22M | $12M | $11M | $6.4K | $26M | $42M | $1M | $15M | $794.0K | $3M | |
| Net Stock Activity | $22M | $12M | $11M | $6.4K | $26M | $42M | $1M | · | $794.0K | · | |
| Financing Cash Flow | $22M | $12M | $11M | $6.4K | $26M | $42M | $1M | $15M | $794.0K | $3M | |
| Net Change in Cash | $6M | $-5M | $-14M | $-18M | $11M | $25M | $-7M | $8M | $-1M | $1M | |
| Free Cash Flow | · | · | · | $-18M | $-14M | $-14M | $-7M | · | $-2M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -227.2% | -285.4% | -172.6% | -86.3% | -52.8% | -102.8% | -166.4% | · | -209.1% | · | |
| ROE | -347.0% | -1285.3% | -313.0% | -95.4% | -45.3% | -66.6% | -325.1% | · | -322.8% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 0.8 | 2.3 | 7.6 | 24.7 | 68.1 | 5.8 | · | 0.2 | · | |
| Quick Ratio | 3.6 | 0.6 | 2.1 | 7.5 | 24.4 | 60.6 | 3.9 | · | 0.2 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -1752.6 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | |
| Receivables Turnover | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.42 | $0.15 | $4.99 | $0.46 | $0.86 | $0.72 | $0.16 | · | $0.04 | · | |
| Cash / Share | $2.38 | $0.15 | $4.53 | $0.44 | $0.81 | $0.63 | $0.10 | · | $0.01 | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-16M | $-21M | $-31M | $-24M | $-21M | $-18M | $-11M | $-12M | $-3M | · | |
| Market Cap | $6M | $463M | $684M | $139.51B | $125.43B | $357.88B | $12.33B | · | · | · | |
| P/B | 0.7 | 285.6 | 92.2 | 6263.0 | 3038.8 | 11575.6 | 4077.6 | · | · | · | |
| P / Tangible Book | 0.7 | 285.6 | 102.9 | 6466.9 | 3086.8 | 11805.3 | · | · | · | · | |
| P / Cash Flow | -0.4 | -27.0 | -27.6 | -7846.8 | -8780.7 | -25681.7 | -1782.0 | · | · | · | |
| P / FCF | · | · | · | -7846.8 | -8761.3 | -25649.4 | -1773.4 | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $3M | $4M | $5M | $4M | $5M | $3M | $3M | |
| SG&A Expense | $2M | $2M | $1M | $1M | $2M | $1M | $1M | $2M | $5M | $3M | $2M | $3M | $4M | $4M | $3M | $3M | |
| Operating Expenses | $4M | $4M | $4M | $3M | $5M | $4M | $4M | $4M | $7M | $6M | $6M | $8M | $8M | $9M | $7M | $6M | |
| Operating Income | $-4M | $-4M | $-4M | $-3M | $-5M | $-4M | $-4M | $-4M | $-7M | $-6M | $-6M | $-8M | $-8M | $-9M | $-7M | $-6M | |
| Interest Income | · | · | · | $2.4K | $6.9K | $4.8K | · | $8.1K | $23.1K | $27.7K | $39.7K | $51.4K | $55.5K | $68.5K | $55.6K | $27.9K | |
| Other Non-op | · | · | · | $-455.5K | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | $-4M | $-6M | $-6M | $-6M | $-8M | $-8M | $-9M | $-7M | $-6M | |
| EPS (Basic) | $-9.40 | $-0.64 | $-11.97 | $-5.00 | $-185.30 | $-12.98 | $-198.38 | $-61.65 | $-3.00 | $-3.86 | $-3.62 | $-5.36 | $-6.14 | $-7.44 | $-19.44 | $-0.13 | |
| Shares (Basic) | 473,162 | 6,951,999 | · | 760,502 | 25,229 | 305,326 | · | 70,013 | 2,161,961 | 1,618,240 | · | 1,445,172 | 1,299,505 | 1,236,822 | · | 47,984,724 | |
| EBITDA | $-4M | $-4M | · | $-3M | $-5M | $-4M | · | $-4M | $-7M | $-6M | · | $-8M | $-8M | $-9M | · | $-6M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $18M | $8M | $1M | $1M | $3M | $2M | $1M | $2M | $8M | $7M | $12M | $10M | $18M | $21M | $26M | |
| Receivables | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $34.9K | $34.9K | |
| Prepaid Expense | $688.6K | $753.8K | $525.9K | $611.8K | $709.3K | $695.4K | $475.8K | $429.2K | $2M | $1M | $794.1K | $1M | $2M | $2M | $484.2K | $757.3K | |
| Current Assets | $16M | $19M | $8M | $2M | $2M | $4M | $2M | $2M | $4M | $9M | $8M | $13M | $12M | $20M | $21M | $26M | |
| PP&E (Net) | · | · | $0 | · | · | · | $0 | $463 | $1.7K | $4.0K | $7.9K | $11.5K | $15.2K | $19.0K | $23.0K | $29.1K | |
| Intangibles | · | · | · | · | · | · | · | $0 | $0 | $790.5K | $773.5K | $763.5K | $741.7K | $721.7K | $702.1K | $682.1K | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | |
| Total Assets | $17M | $20M | $10M | $4M | $4M | $6M | $4M | $4M | $7M | $13M | $11M | $17M | $16M | $23M | $25M | $30M | |
| Accounts Payable | $293.6K | $2M | $743.1K | $2M | $930.8K | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $442.9K | $683.9K | |
| Current Liabilities | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $4M | $3M | $4M | $4M | $5M | $3M | $2M | |
| Total Liabilities | $2M | $3M | $2M | $3M | · | · | $3M | · | · | · | · | · | · | · | · | · | |
| Common Stock | $506 | $9.0K | $3.3K | $1.0K | $33.1K | $24.2K | $217 | $5.5K | $2.6K | $1.9K | $1.5K | $59.4K | $52.0K | $52.0K | $1.2K | $48.0K | |
| Paid-in Capital | $195M | $192M | $179M | $168M | $165M | $163M | $156M | $152M | $150M | $148M | $141M | $140M | $132M | $130M | $125M | $122M | |
| Retained Earnings | $-180M | $-175M | $-171M | $-167M | $-163M | $-159M | $-155M | $-150M | $-146M | $-140M | $-134M | $-128M | $-120M | $-112M | $-103M | $-95M | |
| Stockholders' Equity | $15M | $17M | $8M | $767.8K | $1M | $4M | $2M | $2M | $4M | $9M | $7M | $12M | $12M | $18M | $22M | $27M | |
| Liabilities + Equity | $17M | $20M | $10M | $4M | $4M | $6M | $4M | $4M | $7M | $13M | $11M | $17M | $16M | $23M | $25M | $30M | |
| Shares Outstanding | 506,218 | 9,044,856 | 3,291,488 | 1,004,247 | 33,145,048 | 24,154,348 | 217,234 | 5,489,152 | 2,555,735 | 1,922,586 | 1,485,902 | 59,429,822 | 51,979,078 | 51,974,078 | 1,202,677 | 48,020,324 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | · | $184.2K | · | $420.2K | $2M | $516.0K | $1M | $1M | $2M | $1M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | · | · | |
| Operating Cash Flow | $-5M | $-3M | $-4M | $-3M | $-4M | $-4M | $-4M | $-3M | $-7M | $-5M | $-5M | $-5M | $-8M | $-7M | $-5M | $-4M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | $0 | $-1 | $773.5K | $790.5K | $-15.8K | $-9.8K | $-21.8K | $-20.0K | $-19.6K | $-20.0K | $-85.5K | |
| Stock Issued | $2M | $13M | $11M | $3M | $2M | $6M | $4M | $1M | $20.8K | $7M | $4 | $7M | $0 | $4M | $4.7K | $1.8K | |
| Net Stock Activity | · | $13M | · | · | · | $6M | · | · | · | $7M | · | · | · | $4M | · | · | |
| Financing Cash Flow | $2M | $13M | $11M | $3M | $2M | $6M | $4M | $1M | $20.8K | $7M | $4 | $7M | $0 | $4M | $4.7K | $1.8K | |
| Net Change in Cash | $-3M | $10M | $7M | $-243.5K | $-2M | $2M | $113.4K | $-970.7K | $-6M | $1M | $-5M | $2M | $-8M | $-3M | $-5M | $-5M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -42.4% | -33.9% | · | -101.7% | -89.6% | -42.7% | · | -42.0% | -57.7% | -33.3% | · | -33.3% | -31.6% | -29.3% | · | -16.0% | |
| ROE | -54.9% | -42.9% | · | -312.3% | -163.0% | -62.8% | · | -61.8% | -79.2% | -43.8% | · | -38.9% | -35.9% | -33.2% | · | -16.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 5.6 | · | 0.7 | 0.8 | 1.9 | · | 0.9 | 1.9 | 2.4 | · | 3.0 | 3.2 | 4.1 | · | 10.7 | |
| Quick Ratio | 6.5 | 5.4 | · | 0.4 | 0.6 | 1.6 | · | 0.7 | 1.1 | 2.2 | · | 2.7 | 2.6 | 3.7 | · | 10.4 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $29.23 | $1.87 | · | $0.76 | $0.04 | $0.16 | · | $0.30 | $1.70 | $4.55 | · | $0.21 | $0.23 | $0.36 | · | $0.57 | |
| Cash / Share | $29.94 | $2.00 | · | $1.10 | $0.04 | $0.14 | · | $0.27 | $0.96 | $4.27 | · | $0.20 | $0.19 | $0.35 | · | $0.53 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-16M | $-17M | · | $-17M | $-17M | $-19M | · | $-23M | $-26M | $-28M | · | $-31M | $-30M | $-28M | · | $-24M | |
| Market Cap | $262.7K | $16M | · | $8M | $378M | $296M | · | $99M | $241M | $286M | · | $46.95B | $98.66B | $94.59B | · | $135.42B | |
| P/B | 0.0 | 1.0 | · | 11.1 | 271.6 | 76.5 | · | 59.7 | 55.4 | 32.7 | · | 3815.3 | 8186.7 | 5117.3 | · | 4926.3 | |
| P / Tangible Book | 0.0 | 1.0 | · | 11.1 | 271.6 | 76.5 | · | 59.7 | 55.4 | 36.0 | · | 4067.7 | 8723.6 | 5325.2 | · | 5051.7 | |
| P / Cash Flow | · | -5.2 | · | · | · | -71.1 | · | · | · | -54.1 | · | · | · | -13645.0 | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Ricavi | · | $0 | $0 | $0 | · |
| Utile netto | $-16M | $-21M | $-31M | $-24M | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Rapporto corrente | 3.8 | 0.8 | 2.3 | 7.6 | · |
| Quick Ratio | 3.6 | 0.6 | 2.1 | 7.5 | · |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | $-18M | · |
Proprietari istituzionali (13F) 26 filer · $117K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
26
Valore detenuto
$117K
Nuove posizioni
5
Posizioni chiuse
8
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 5 (-6 vs trimestre precedente) | 8 (+4 vs trimestre precedente) | 4 (+2 vs trimestre precedente) | 4 (+2 vs trimestre precedente) | +205K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | $40.536 | 78.104 | 34,53% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $31.319 | 60.348 | 26,67% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $18.866 | 36.350 | 16,07% | Azioni |
| Engineers Gate Manager LP | $10.839 | 20.885 | 9,23% | Azioni |
| Mayflower Financial Advisors, LLC | $10.380 | 20.000 | 8,84% | Azioni |
| UBS Group AG | $2.330 | 4.489 | 1,98% | Azioni |
| Tower Research Capital LLC (TRC) | $1.478 | 2.847 | 1,26% | Azioni |
| BARCLAYS PLC | $819 | 1.578 | 0,70% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $597 | 1.208 | 0,51% | Azioni |
| BlackRock, Inc. | $98 | 188 | 0,08% | Azioni |
| OSAIC HOLDINGS, INC. | $41 | 82 | 0,03% | Azioni |
| HRT FINANCIAL LP | $37 | 72.061 | 0,03% | Azioni |
| SBI Securities Co., Ltd. | $25 | 48 | 0,02% | Azioni |
| Bernard Wealth Management Corp. | $16 | 30 | 0,01% | Azioni |
| Allworth Financial LP | $12 | 23 | 0,01% | Azioni |
| HighMark Wealth Management LLC | $5 | 10 | 0,00% | Azioni |
| MORGAN STANLEY | $3 | 6 | 0,00% | Azioni |
| Nemes Rush Group LLC | $3 | 5 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $1 | 2 | 0,00% | Azioni |
| Global Retirement Partners, LLC | $1 | 1 | 0,00% | Azioni |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0,00% | Azioni |
| Bogart Wealth, LLC | $1 | 1 | 0,00% | Azioni |
| DANSKE BANK A/S | $1 | 1 | 0,00% | Azioni |
| GROUP ONE TRADING LLC | $1 | 1 | 0,00% | Azioni |
| Capital Advisors, Ltd. LLC | $0 | 1 | 0,00% | Azioni |
| Motiv8 Investments LLC | $0 | 1 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| John Rodney Varner (2) | 15 Febbraio 2019 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 16 insider · 7 dirigenti · 8 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ryan M. Confer | President, CEO and CFO | 27 Febbraio 2026 F | 36.331 | 0 | 0 | $0 |
| John Rodney Varner | Chairman, President and CEO | 18 Febbraio 2024 F | 26.352 | 0 | 0 | $0 |
| Julien L Pham | President & COO | 25 Gennaio 2019 A | 500 | 0 | 0 | $0 |
| Michael Thomas Redman | EVP & Chief Operating Officer | 19 Marzo 2021 A | · | 0 | 0 | $0 |
| Mark Stanley Berger | Chief Medical Officer | 27 Febbraio 2026 F | 21.692 | 0 | 0 | $0 |
| Catherine M Vaczy | EVP GC Chief Strategy Officer | 21 Aprile 2023 P | 265.000 | 0 | 0 | $0 |
| Hermant Kumar | Chief Mfgr & Tech Officer | 18 Febbraio 2023 A | 200.000 | 0 | 0 | $0 |
| Brent M Longnecker | Direttore | 14 Aprile 2026 S | 0 | 0 | 2 | $-22 |
| William R Wilson Jr. | Direttore | 22 Dicembre 2025 A | 9.157 | 0 | 0 | $0 |
| Toscano Jose Antonio Moreno | Direttore | 22 Dicembre 2025 A | 9.157 | 0 | 0 | $0 |
| David E. Friedman | Direttore | 30 Dicembre 2019 A | · | 0 | 0 | $0 |
| Robert W. Pearson | Direttore | 30 Dicembre 2019 A | · | 0 | 0 | $0 |
| Genprex, Inc. | Direttore | 02 Novembre 2018 A | · | 0 | 0 | $0 |
| Viet-An Hoan Ly | Proprietario del 10% | 27 Settembre 2018 J | 36.067 | 0 | 0 | $0 |
| Christy M. Nance | Proprietario del 10% | 29 Marzo 2018 P | 50.000 | 0 | 0 | $0 |
| Jack A Roth | Proprietario del 10% | 29 Marzo 2018 P | 1.338.999 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 36.350 SH | 19 Agosto 2026 | Giornaliero |
GNPX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 7 analisti
COMPRA
2 28,6%
Acquisto forte
4 57,1%
Compra
1 14,3%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 14, 2026